查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1608936

畜牧药品市场：依功效、给药途径、家畜、通路分类 - 全球预测 2025-2030

Livestock Medicine Market by Medication (Drugs, Medicated Feed Additives, Vaccines), Route of Administration (Injectable, Oral, Topical), Livestock Animals, Distribution Channels - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年畜牧药品市场价值为169.2亿美元，预计到2024年将达到179.2亿美元，复合年增长率为5.60%，到2030年将达到247.8亿美元。

畜牧药品包括维持和改善畜禽健康和生产力的药品、疫苗、饲料添加剂和其他保健食品。这一领域对于满足世界对动物源产品不断增长的需求至关重要，并且需要改进牲畜保健方法。应用范围从疫苗接种计划等预防措施到对抗家禽、牛、猪和其他牲畜疾病的治疗剂。最终用途包括农场、兽医院、动物照护中心等。肉类和乳製品消费量的增加、兽医技术的进步、动物健康意识的提高以及支持牲畜福利的法律规范推动了市场成长。新兴市场的快速都市化和收入增加将进一步推动对优质畜产品的需求，带来巨大的成长机会。然而，挑战依然存在，包括严格的监管、高昂的开发成本以及与抗生素抗药性相关的问题。原料价格的波动和新兴的通用感染疾病增加了市场动态的复杂性。新疫苗的开发、精准畜牧技术以及益生菌和植物来源添加剂等抗生素替代品等领域的创新可能会蓬勃发展。製药公司和农业综合相关企业之间的策略联盟可以产生协同效应并加强产品供应和分销管道。为了利用潜在的机会，相关人员应专注于旨在永续解决方案的研发投资，并优先考虑与监管机构的透明沟通，以加快产品核可。此外，透过利用资料分析进行预测疾病建模和客製化治疗计划，可以显着优化动物健康管理。透过专注于这些创新路径并透过策略规划和合作克服现有挑战，市场参与企业可以有效地利用畜牧药品市场现有和新兴的机会。

主要市场统计
基准年[2023] 169.2亿美元
预计年份 [2024] 179.2亿美元
预测年份 [2030] 247.8亿美元
复合年增长率（%） 5.60%

市场动态：快速发展的畜牧药品市场的关键市场洞察

供需的动态交互作用正在改变牲畜药品市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球牲畜数量增加
    • 牲畜传染病爆发
    • 增加牲畜疫苗的使用
  • 市场限制因素
    • 发展中地区牲畜药物的供应与认知有限
    • 存在假冒伪劣药品
  • 市场机会
    • 人们对牲畜健康和福利的认识不断增强
    • 畜牧业投资快速成长
    • 畜牧新药开发研究与开发
  • 市场挑战
    • 增加牲畜的抗菌素抗药性
    • 药物可能对牲畜产生不利影响

波特五力战略工具驾驭畜牧药品市场

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解畜牧药品市场的外部影响

外部宏观环境因素对畜牧药品市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解畜牧药品市场竞争状况

兽药市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 兽药市场定位矩阵供应商绩效评估

FPNV定位矩阵是评估畜牧药品市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划兽药市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对牲畜药品市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球牲畜数量增加
      • 畜禽传染病发生现状
      • 增加牲畜疫苗的使用
    • 抑制因素
      • 发展中地区牲畜药物的供应与认知有限
      • 存在假冒伪劣药品
    • 机会
      • 提高牲畜健康和保健意识
      • 畜牧业投资快速成长
      • 畜牧新药开发研究与开发
    • 任务
      • 增加牲畜的抗菌素抗药性
      • 药物对牲畜的潜在不良影响
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章畜牧药品市场依药品分类

  • 药品
    • 抗感染
    • 发炎（药
    • 驱虫药
  • 医药添加剂和饲料添加剂
    • 胺基酸
    • 抗生素
    • 抗氧化剂
    • 酵素
    • 益生元和益生菌
    • 维他命
  • 疫苗
    • 灭活疫苗
    • 减毒活病毒疫苗

第七章畜牧药品市场：依管理途径

  • 可注射的
  • 口服
  • 话题

第八章畜牧业医药市场

  • 牛
  • 鱼
  • 家禽
  • 猪

第九章畜牧药品市场依通路划分

  • 离线
    • 药局
    • 兽医诊所
  • 在线的

第十章美洲畜牧药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太畜牧药品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲畜牧药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc.
  • HESTER BIOSCIENCES LIMITED
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Nutreco NV
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Vetpharma Animal Health SL
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-FE3E5C0AE72F

The Livestock Medicine Market was valued at USD 16.92 billion in 2023, expected to reach USD 17.92 billion in 2024, and is projected to grow at a CAGR of 5.60%, to USD 24.78 billion by 2030.

Livestock medicine encompasses pharmaceuticals, vaccines, feed additives, and other health products designed to maintain and enhance the health and productivity of farm animals. This sector is critical for fulfilling the rising global demand for animal-derived products, necessitating advancements in livestock healthcare practices. Applications range from preventive measures, such as vaccination programs, to therapeutics addressing diseases that affect poultry, cattle, swine, and other livestock. The end-use scope includes farms, veterinary hospitals, and animal care centers. Market growth is driven by rising consumption of meat and dairy products, technological advancements in veterinary care, increased awareness of animal health, and regulatory frameworks supporting livestock welfare. Rapid urbanization and income growth in emerging markets further fuel demand for quality animal products, presenting significant opportunities. Yet, challenges persist, notably stringent regulations, high costs of development, and issues related to antibiotic resistance. The volatility of raw material prices and emerging zoonotic diseases add complexity to market dynamics. Innovation can thrive in areas like the development of novel vaccines, precision livestock farming technologies, and alternatives to antibiotics such as probiotics and plant-based additives. Strategic alliances between pharma companies and agricultural entities can create synergies, enhancing product offerings and distribution channels. To harness potential opportunities, stakeholders should focus on R&D investments aimed at sustainable solutions and prioritize transparent communication with regulatory bodies to expedite product approvals. Additionally, leveraging data analytics for predictive disease modeling and customizing treatment plans can significantly optimize animal health management. By concentrating on these innovation avenues and overcoming existing challenges through strategic planning and collaboration, market participants can effectively capitalize on existing and emerging opportunities in the livestock medicine market.

KEY MARKET STATISTICS
Base Year [2023] USD 16.92 billion
Estimated Year [2024] USD 17.92 billion
Forecast Year [2030] USD 24.78 billion
CAGR (%) 5.60%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Livestock Medicine Market

The Livestock Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growth in livestock population globally
    • Incidences of livestock infectious diseases
    • Rising usage of vaccines among livestock
  • Market Restraints
    • Limited availability and awareness of livestock medicine in developing areas
    • Presence of counterfeit or substandard drugs
  • Market Opportunities
    • Increasing awareness for livestock health & wellness
    • Surge in investment in the livestock industry
    • R&D for novel livestock drug development
  • Market Challenges
    • Rise in antimicrobial resistance in livestock
    • Potential adverse impact of medication on livestock

Porter's Five Forces: A Strategic Tool for Navigating the Livestock Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Livestock Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Livestock Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Livestock Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Livestock Medicine Market

A detailed market share analysis in the Livestock Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Livestock Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Livestock Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Livestock Medicine Market

A strategic analysis of the Livestock Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Livestock Medicine Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc., HESTER BIOSCIENCES LIMITED, Indian Immunologicals Ltd., Merck & Co., Inc., Neogen Corporation, Nutreco N.V., Phibro Animal Health Corporation, Vetoquinol S.A., Vetpharma Animal Health S.L., Virbac SA, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Livestock Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Medication, market is studied across Drugs, Medicated Feed Additives, and Vaccines. The Drugs is further studied across Anti-infectives, Anti-inflammatory, and Antiparasitic. The Medicated Feed Additives is further studied across Amino acids, Antibiotics, Antioxidants, Enzymes, Prebiotics & Probiotics, and Vitamins. The Vaccines is further studied across Killed Inactivated Vaccines and Modified Live Vaccines.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Livestock Animals, market is studied across Cattle, Fish, Poultry, and Swine.
  • Based on Distribution Channels, market is studied across Offline and Online. The Offline is further studied across Pharmacy and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth in livestock population globally
      • 5.1.1.2. Incidences of livestock infectious diseases
      • 5.1.1.3. Rising usage of vaccines among livestock
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability and awareness of livestock medicine in developing areas
      • 5.1.2.2. Presence of counterfeit or substandard drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing awareness for livestock health & wellness
      • 5.1.3.2. Surge in investment in the livestock industry
      • 5.1.3.3. R&D for novel livestock drug development
    • 5.1.4. Challenges
      • 5.1.4.1. Rise in antimicrobial resistance in livestock
      • 5.1.4.2. Potential adverse impact of medication on livestock
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Livestock Medicine Market, by Medication

  • 6.1. Introduction
  • 6.2. Drugs
    • 6.2.1. Anti-infectives
    • 6.2.2. Anti-inflammatory
    • 6.2.3. Antiparasitic
  • 6.3. Medicated Feed Additives
    • 6.3.1. Amino acids
    • 6.3.2. Antibiotics
    • 6.3.3. Antioxidants
    • 6.3.4. Enzymes
    • 6.3.5. Prebiotics & Probiotics
    • 6.3.6. Vitamins
  • 6.4. Vaccines
    • 6.4.1. Killed Inactivated Vaccines
    • 6.4.2. Modified Live Vaccines

7. Livestock Medicine Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Livestock Medicine Market, by Livestock Animals

  • 8.1. Introduction
  • 8.2. Cattle
  • 8.3. Fish
  • 8.4. Poultry
  • 8.5. Swine

9. Livestock Medicine Market, by Distribution Channels

  • 9.1. Introduction
  • 9.2. Offline
    • 9.2.1. Pharmacy
    • 9.2.2. Veterinary Clinics
  • 9.3. Online

10. Americas Livestock Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Livestock Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Livestock Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Biogenesis Bago SA
  • 2. Boehringer Ingelheim International GmbH
  • 3. Ceva Sante Animale
  • 4. Dechra Pharmaceuticals PLC
  • 5. Elanco Animal Health Inc.
  • 6. HESTER BIOSCIENCES LIMITED
  • 7. Indian Immunologicals Ltd.
  • 8. Merck & Co., Inc.
  • 9. Neogen Corporation
  • 10. Nutreco N.V.
  • 11. Phibro Animal Health Corporation
  • 12. Vetoquinol S.A.
  • 13. Vetpharma Animal Health S.L.
  • 14. Virbac SA
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. LIVESTOCK MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. LIVESTOCK MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. LIVESTOCK MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. LIVESTOCK MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LIVESTOCK MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LIVESTOCK MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIOXIDANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY KILLED INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MODIFIED LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 340. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND LIVESTOCK MEDICINE MARKET S